These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7211184)

  • 1. Effects of withdrawal from long-term diphenylhydantoin treatment on audiogenic and maximal electroshock-induced seizures in rats.
    De Lima TC; Palermo Neto J
    Acta Neurol Scand; 1981 Mar; 63(3):189-96. PubMed ID: 7211184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of withdrawal from long-term barbital treatment on open-field behaviour and seizure susceptibility of rats.
    Palermo-Neto J; De Lima TC
    Neuropharmacology; 1982 Mar; 21(3):277-81. PubMed ID: 6122187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system supersensitivity and withdrawal from long-term diphenylhydantoin treatment.
    De-Lima TC; Palermo-Neto J
    Braz J Med Biol Res; 1983 Oct; 16(3):241-5. PubMed ID: 6686073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative assessment of the anticonvulsant activity of some benzodiazepines, phenobarbitone and diphenylhydantoin against maximal electroshock seizures in rats: a time-distribution study.
    Banerjee U; Yeoh PN
    Med Biol; 1981 Aug; 59(4):253-8. PubMed ID: 6121957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system supersensitivity and withdrawal from long-term treatment with barbital.
    Sandoval MR; Palermo-Neto J
    Neuropharmacology; 1985 Dec; 24(12):1247-51. PubMed ID: 4094660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of acoustic priming in mice.
    Lieff BD; Sharpless SK; Schlesinger K
    J Comp Physiol Psychol; 1976 Aug; 90(8):773-9. PubMed ID: 965525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diphenylhydantoin potency and plasma protein binding.
    Shoeman DW; Azarnoff DL
    J Pharmacol Exp Ther; 1975 Oct; 195(1):84-6. PubMed ID: 1181407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved anticonvulsant activity of phenytoin by a redox brain delivery system. III: Brain uptake and pharmacological effects.
    Shek E; Murakami T; Nath C; Pop E; Bodor NS
    J Pharm Sci; 1989 Oct; 78(10):837-43. PubMed ID: 2600790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the brain-stem reticular formation in tonic-clonic seizures: lesion and pharmacological studies.
    Browning RA
    Fed Proc; 1985 May; 44(8):2425-31. PubMed ID: 3886430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of baclofen, gamma-hydroxybutyric acid and muscimol on the protective action of phenobarbital and diphenylhydantoin against maximal electroshock-induced seizures in mice.
    Czuczwar SJ; Chmielewska B; Turski WA; Kleinrok Z
    Neuropharmacology; 1984 Feb; 23(2A):159-63. PubMed ID: 6717755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of diphenylhydantoin on rat behavior.
    De Lima TC; Palermo Neto J
    Psychopharmacology (Berl); 1980; 69(2):183-5. PubMed ID: 6779311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative activity of delta9-tetrahydrocannabinol, diphenylhydantoin, phenobarbital and chlordiazepoxide on electroshcok seizure threshold in mice.
    Sofia RD; Barry H
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):73-8. PubMed ID: 921404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant activity of reaction products of 5,5-diphenylhydantoin with substituted methylene bromides.
    Usifoh CO
    Arch Pharm (Weinheim); 2001 Nov; 334(11):366-8. PubMed ID: 11822175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-affinity kainate receptor-mediated events reduce the protective activity of phenobarbital and diphenylhydantoin against maximal electroshock in mice.
    Borowicz KK; Zadrozniak M; Czuczwar SJ
    Neuropharmacology; 2002 Dec; 43(7):1082-6. PubMed ID: 12504914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsant activity of delta9-tetrahydrocannabinol compared with three other drugs.
    Sofia RD; Solomon TA; Barry H
    Eur J Pharmacol; 1976 Jan; 35(1):7-16. PubMed ID: 1253828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between concentration and anticonvulsant effect of phenytoin against electroshock-induced seizures in rats: comparison of sampling sites for concentration determinations.
    Ramzan I; Levy G
    J Pharm Sci; 1989 Jun; 78(6):448-51. PubMed ID: 2760817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of three N-(carboxyanilinomethyl) derivatives of p-isopropoxyphenylsuccinimide on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model.
    Luszczki JJ; Cioczek JD; Kocharov SL; Andres-Mach M; Kominek M; Zolkowska D
    Eur J Pharmacol; 2010 Dec; 648(1-3):74-9. PubMed ID: 20826140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EFFECTS OF DIPHENYLHYDANTOIN ON ELECTROSHOCK SEIZURE THRESHOLDS IN DEVELOPING RATS.
    VERNADAKIS A; WOODBURY DM
    J Pharmacol Exp Ther; 1965 May; 148():144-50. PubMed ID: 14301005
    [No Abstract]   [Full Text] [Related]  

  • 19. Folic acid and the protective action of diphenylhydantoin against maximal electroshock in rats after single doses.
    van Rees H; Telkers-Duijts GA; Noach EL
    Arch Int Pharmacodyn Ther; 1983 Jan; 261(1):16-22. PubMed ID: 6847314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced taurine contents and modification of anticonvulsive effects of phenobarbital and phenytoin by guanidinoethane sulfonate in mice.
    Izumi K; Kishita C; Nakagawa K; Huxtable RJ; Shimizu T; Koja T; Fukuda T
    Prog Clin Biol Res; 1985; 179():425-34. PubMed ID: 4059222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.